Huang Reportedly Also Had a Relationship With Nvidia's Vice President of Healthcare, Per NYT

A Second Relationship, This One Internal

The first affair put Jensen Huang next to a suspected Chinese spy. The second one puts him next to his own org chart.

Jensen Huang of Nvidia reportedly also had a relationship with Nvidia's vice president of healthcare, per the New York Times. The Times was the first to report the second affair, before the Wall Street Journal reported Wednesday that Nvidia's board is preparing to oust its founder and chief executive.

The executive is one of Huang's direct reports. That single fact changes the character of the scandal: a relationship with a subordinate is a workplace conduct and governance issue entirely apart from the espionage questions swirling around Alice Huang, the Megaspeed executive at the center of the federal investigation.

Two Affairs, Two Different Crises

Huang's Sunday letter to staff admitted he had been unfaithful and apologized for violating his family's and his employees' trust. The board has opened an independent investigation after reports that Huang was the target of a foreign intelligence effort. Shareholders have filed a proposed class action. The FBI and the Justice Department are investigating the Megaspeed channel.

The healthcare relationship adds a crisis that does not need a single classified fact to damage the company. It raises immediate questions about disclosure to the board, about the executive's role and advancement, and about what Nvidia's human resources and compliance functions knew. Those are the questions an independent board investigation is designed to answer, and they are the hardest ones for a founder-CEO to survive.

Do you want to see how to make more plays? Do you want to find gains yourself? Unusual Whales helps you find market opportunities through our market tide, historical options flow, GEX, and much, much more. Create a free account here to start conquering the market with Unusual Whales

Options and Market Impact

Investors are pricing a leadership vacuum. Nvidia fell about 8% after hours on the board-ouster report, after Monday's 4.27% drop to $178.67 erased roughly $190 billion in market value. Prediction markets put Huang's odds of leaving by year end at 77%.

Healthcare is not a side business at Nvidia; it is one of the verticals the company has used to prove AI demand extends beyond hyperscalers. Any personnel fallout in that division is a fundamental headline, not a tabloid one. Nvidia options remain an event market: implied volatility elevated, ranges wide, and every board update a potential multi-percent move.

Bottom Line

One affair made Huang a counterintelligence problem. The other makes him a governance problem, and it happened with an executive whose career sat in his hands. Boards can survive a CEO's scandal in the newspapers. They rarely survive one in the reporting line.

Follow the flow on these names and the rest of the market with Unusual Whales. Create a free account here to start conquering the market with Unusual Whales.

Track NVDA on Unusual Whales
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.